Work

Dose-Ranging Pharmacodynamic Study of Tipifarnib (R115777) in Patients With Relapsed and Refractory Hematologic Malignancies

Year: 2004

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.03.200

Authors: Todd M. Zimmerman, Helena Harlin, Olatoyosi M. Odenike, Seth Berk, Evie Sprague, Theodore Karrison, Wendy Stock, Richard A. Larson, Mark J. Ratain, Thomas F. Gajewski

Institution: University of Chicago

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1313969261, G4141258567, G6177210922, Novel Therapies for Myeloma and Related Malignancies, Phase I Clinical Trials of Anti-Cancer Agents

OpenAlex ID: W2172062373

FWCI: 3.206

Cites: 20

Cited by: 43

Related to: 10